Patent Assignment
Reel/Frame 067184/0175
Assignment of Assignor's Interest
Recorded: 2024-04-22
Pages: 14
Assignor
2SEVENTY BIO, INC.
Executed: 2024-04-01
Assignee
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER RD, TARRYTOWN, NEW YORK, 10591-6707
Covered Properties
(2)
Cll-1 Targeted Immunotherapies
Cll-1 Targeted Immunotherapies
Application:
62/845,306 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 22, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 049822/0562 →
Assignment of Assignor's Interest
Aug 16, 2019
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 050069/0688 →
Assignment of Assignor's Interest
Sep 14, 2021
From: BLUEBIRD BIO, INC.
To: 2SEVENTY BIO, INC.
Reel/Frame 057683/0099 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0824 →
Assignment of Assignor's Interest
Sep 1, 2022
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 060969/0480 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →